866-997-4948(US-Canada Toll Free)

Parkinsons Disease Global Clinical Trials Review, H1, 2018

Published By :

GlobalData

Published Date : Apr 2018

Category :

Pharmaceutical

No. of Pages : 854 Pages

Parkinson's Disease Global Clinical Trials Review, H1, 2018

Summary

GlobalData's clinical trial report, Parkinson's Disease Global Clinical Trials Review, H1, 2018" provides an overview of Parkinson's Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Parkinson's Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Parkinson's Disease to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Parkinson's Disease to Central Nervous System Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Parkinson's Disease Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Parkinson's Disease 31
Apr 30, 2018: Elto PharmaAppoints Paula Trzepacz, MD as Chief Medical Advisor 31
Apr 26, 2018: Intra-Cellular Therapies Presents Data on ITI-214 at the 2018 American Academy of Neurology Annual Meeting 31
Apr 24, 2018: Intec Pharma Presented Phase 1 PK and Safety Data From Accordion Pill Carbidopa/Levodopa at American Academy of Neurology Annual Meeting 32
Apr 19, 2018: Adamas Announces Final Results from the Two-Year Phase 3 Open-Label Study of GOCOVRI in Parkinson's Disease Patients with Dyskinesia 32
Apr 18, 2018: Mitsubishi Tanabe Pharma America and NeuroDerm Announce Parkinson's Disease Presentations at American Academy of Neurology Annual Meeting 33
Apr 17, 2018: Anavex Life Sciences to Initiate Phase 2 Study of ANAVEX2-73 in Parkinsons Disease Dementia and Provides Clinical Study Update for ANAVEX2-73 in Rett Syndrome 33
Apr 12, 2018: Adamas Announces Data Presentations on GOCOVRI at The American Academy Of Neurology Annual Meeting 34
Apr 12, 2018: Bumetanide strikes again in the arena of neurological disorders: a novel therapeutic approach to treat Parkinsons disease 34
Apr 10, 2018: Approval For Rotigotine Extended Release Microspheres For Injection From Phase III Clinical Trials In China 35
Apr 04, 2018: Intec Pharma Announces Poster Presentation at American Academy of Neurology Annual Meeting 35
Apr 03, 2018: Intec Pharma to Host Key Opinion Leader Luncheon on Novel Drug Delivery Solutions in the Treatment of Parkinson's Disease 35
Mar 29, 2018: Herantis Pharma publishes an introductory video on its drug candidate CDNF for the treatment of Parkinson's disease 36
Mar 26, 2018: Enterin's Phase 2a RASMET Study in Patients With Parkinson's Disease Completes Enrollment 36
Mar 15, 2018: Biogen to Present at the 2018 Advances in Alzheimers and Parkinsons Therapies (AAT-AD/PD) Focus Meeting 37
Mar 15, 2018: Aptinyx Presents Data on NMDA Receptor Modulator NYX-458 in a Preclinical Model of Parkinson's Cognitive Impairment at the AAT-AD/PD Focus Meeting 2018 37
Mar 15, 2018: Adamas Announces Publication of Data Supporting the Benefits of GOCOVRI in Parkinson Disease Patients with Dyskinesia 38
Mar 09, 2018: Voyager Therapeutics Announces Longer-Term Data from Ongoing Phase 1b Trial of VY-AADC for Advanced Parkinsons Disease 38
Mar 05, 2018: International Stem Cell Completes Dosing Of Second Cohort In Parkinson's Disease Clinical Trial 40
Feb 27, 2018: Hisamitsu Pharmaceutical Announces the Results of Phase III Clinical Study of HP-3000 in Japan 40
Feb 26, 2018: Cantabio Pharmaceuticals to Present Results from its Tau Protein Targeting Therapeutic Program for the treatment of Alzheimer Disease at the Advances in Alzheimer and Parkinson Therapies, An AAT-AD/PD Focus Meeting in Torino, Italy 40
Feb 26, 2018: Genervon Presents Innovative CNS Drug Candidate at 2018 BIO CEO & Investor Conference 41
Feb 08, 2018: Adamas Announces Publication of Amantadine Immediate Release Subgroup Analysis From EASE LID 2 Open-label Study in Movement Disorders Clinical Practice 41
Feb 08, 2018: Rotigotine Extended Release Microspheres For Injection Exempted From Phase II Clinical Trials in the United States 42
Feb 06, 2018: First Patients Dosed in Phase III Multi-center, Multinational Study to Determine the Efficacy, Safety and Tolerability of P2B001 in Patients with Early Stage Parkinson's Disease 42
Jan 31, 2018: IRLAB Provides Update On Clinical Phase II pipeline - IRL752 42
Jan 31, 2018: IRLAB Provides Update On Clinical Phase II pipeline - IRL790 43
Clinical Trial Profile Snapshots 45
Appendix 852
Abbreviations 852
Definitions 852
Research Methodology 853
Secondary Research 853
About GlobalData 854
Contact Us 854
Source 854

List of Tables
Parkinson's Disease Therapeutics, Global, Clinical Trials by Region, 2018* 8
Parkinson's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Parkinson's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Parkinson's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Parkinson's Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Parkinson's Disease Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Parkinson's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Parkinson's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Parkinson's Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 16
Parkinson's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Parkinson's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Parkinson's Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 19
Parkinson's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Parkinson's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Parkinson's Disease Therapeutics, Global, Clinical Trials by Phase, 2018* 22
Parkinson's Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 23
Parkinson's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Parkinson's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
Parkinson's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 27
Parkinson's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Parkinson's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
Parkinson's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 30

List of Figures
Parkinson's Disease Therapeutics, Global, Clinical Trials by Region (%), 2018* 8
Parkinson's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Parkinson's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Parkinson's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Parkinson's Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Parkinson's Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Parkinson's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Parkinson's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Parkinson's Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 16
Parkinson's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Parkinson's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Parkinson's Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 19
Parkinson's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Parkinson's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Parkinson's Disease Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22
Parkinson's Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 23
Parkinson's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Parkinson's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
Parkinson's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 27
Parkinson's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Parkinson's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
Parkinson's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 30
GlobalData Methodology 853

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *